Cellectis (NASDAQ: CLLS) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.96 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.